Copyright: ©Author(s) 2026.
World J Exp Med. Mar 20, 2026; 16(1): 117464
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.117464
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.117464
Table 3 Predictors of length of hospital stay
| Predictor | Coefficient | 95%CI | P value | Interpretation |
| Intercept | -19.14 | (-110.98 to 72.70) | 0.679 | Baseline length of stay (reference group) |
| Cerebrovascular disease | 6.75 | (0.76 to 12.74) | 0.028 | Adds about 6.7 days to LOS |
| Those who were on SGLT-2 inhibitors | 5.80 | (1.32 to 9.62) | 0.035 | Adds about 5.8 days to LOS |
| COPD | 3.60 | (2.14 to 6.44) | 0.04 | Adds about 3.6 days to LOS |
| Higher NEWS 2 score | 1.14 | (0.10 to 2.18) | 0.033 | Each NEWS 2 point adds about 1.14 days to LOS |
| Systolic BP | -0.18 | (-0.32 to -0.04) | 0.014 | Lower systolic BP predicts longer LOS |
| Acute myocardial infarction | -6.06 | (-12.15 to 0.03) | 0.051 | Shortens LOS by about 6 days (only borderline significance as P > 0.05 and confidence interval crosses 0) |
- Citation: Chandrabalan V, Howcroft T, Alkhalifah MK, Younis N, Aldhafiri E, Pappachan JM. Diabetic ketoacidosis in patients with type 2 diabetes: Risk factors for mortality and adverse outcomes. World J Exp Med 2026; 16(1): 117464
- URL: https://www.wjgnet.com/2220-315x/full/v16/i1/117464.htm
- DOI: https://dx.doi.org/10.5493/wjem.v16.i1.117464